LOGIN
Celecoxib, meloxicam, and paracetamol provide pain relief in Kashin-Beck disease patients
December 2013
Celecoxib, meloxicam, and paracetamol provide pain relief in Kashin-Beck disease patients
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Efficacy of celecoxib, meloxicam and paracetamol in elderly Kashin-Beck disease (KBD) patients
Int Orthop. 2011 Sep;35(9):1409-14. doi: 10.1007/s00264-010-1062-0. Epub 2010 Jun 13Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
168 elderly patients were randomized to examine the efficacy of celecoxib, meloxicam, and paracetamol in treating symptoms of late Kashin-Beck disease. Patients received a six week course of celecoxib 200 mg once daily, meloxicam 7.5 mg once daily or paracetamol 300 mg three times daily. Results revealed that all three treatments were effective in relieving pain throughout the course of 6 weeks; h...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.